Wilmington Savings Fund Society FSB Purchases New Stake in Agilent Technologies, Inc. (NYSE:A)

Wilmington Savings Fund Society FSB acquired a new position in Agilent Technologies, Inc. (NYSE:AFree Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 3,604 shares of the medical research company’s stock, valued at approximately $535,000.

Other hedge funds have also added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA raised its stake in Agilent Technologies by 3.5% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company’s stock valued at $2,314,784,000 after acquiring an additional 525,214 shares during the period. State Street Corp raised its position in shares of Agilent Technologies by 1.2% in the third quarter. State Street Corp now owns 12,819,897 shares of the medical research company’s stock valued at $1,903,498,000 after purchasing an additional 158,175 shares during the period. Geode Capital Management LLC lifted its stake in shares of Agilent Technologies by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 6,948,679 shares of the medical research company’s stock valued at $1,028,241,000 after buying an additional 30,610 shares in the last quarter. Van ECK Associates Corp boosted its holdings in Agilent Technologies by 6.6% in the 3rd quarter. Van ECK Associates Corp now owns 2,976,905 shares of the medical research company’s stock worth $442,011,000 after buying an additional 183,716 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Agilent Technologies by 4.8% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,948,536 shares of the medical research company’s stock valued at $437,799,000 after buying an additional 136,184 shares in the last quarter. Institutional investors own 87.42% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. TD Cowen increased their price objective on Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Wells Fargo & Company cut their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. Evercore ISI upped their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. StockNews.com downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, November 26th. Finally, Barclays decreased their price target on shares of Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating on the stock in a report on Wednesday, November 27th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $143.62.

View Our Latest Analysis on Agilent Technologies

Insider Activity

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. The trade was a 19.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

Agilent Technologies Price Performance

Shares of Agilent Technologies stock opened at $139.00 on Monday. The firm has a market cap of $39.94 billion, a PE ratio of 31.45, a price-to-earnings-growth ratio of 4.48 and a beta of 1.07. The company’s fifty day simple moving average is $136.75 and its two-hundred day simple moving average is $136.37. The company has a quick ratio of 1.58, a current ratio of 2.09 and a debt-to-equity ratio of 0.57. Agilent Technologies, Inc. has a 12-month low of $124.16 and a 12-month high of $155.35.

Agilent Technologies (NYSE:AGet Free Report) last posted its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.05. The company had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The firm’s quarterly revenue was up .8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.38 EPS. As a group, equities analysts expect that Agilent Technologies, Inc. will post 5.56 EPS for the current year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st will be paid a $0.248 dividend. This represents a $0.99 annualized dividend and a dividend yield of 0.71%. The ex-dividend date of this dividend is Tuesday, December 31st. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio is currently 22.40%.

Agilent Technologies Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Featured Articles

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.